SEPTIN9 and esophageal squamous cell carcinoma: It has been reported that SEPT9 is abnormally expressed in ESCC, ovarian, breast, prostate, and colorectal cancers (CRC) and acts as an oncogene or tumor suppressor gene [28, 29, 36–38].